UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

Nature communications, 2018-02, Vol.9 (1), p.741-14, Article 741

2018

Volltextzugriff (PDF)

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (17), p.6337-6343

2004

Volltextzugriff (PDF)

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Science translational medicine, 2015-05, Vol.7 (288), p.288ra78

2015

Volltextzugriff (PDF)

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

PloS one, 2017-11, Vol.12 (11), p.e0188916-e0188916

2017

Volltextzugriff (PDF)

Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma

Cancer immunology research, 2014-08, Vol.2 (8), p.725-731

2014

Volltextzugriff (PDF)

Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma

Clinical cancer research, 2015-01, Vol.21 (1), p.30-38

2015

Volltextzugriff (PDF)

An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission

Clinical cancer research, 2021-12, Vol.27 (24), p.6696-6708

2021

Volltextzugriff (PDF)

Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy

Frontiers in immunology, 2016-03, Vol.7, p.112-112

2016

Volltextzugriff (PDF)

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

The cancer journal (Sudbury, Mass.), 2015-11, Vol.21 (6), p.501

2015

Volltextzugriff (PDF)

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

Clinical cancer research, 2018-12, Vol.24 (23), p.6100-6100

2018

Volltextzugriff (PDF)

Persistence of Non Gene-Modified Adoptively Transferred Marrow Infiltrating Lymphocytes (MILs) More Than Five Years Post Transfer

Blood, 2016-12, Vol.128 (22), p.4552-4552

2016

Volltextzugriff (PDF)

Targeting Immune Suppression with PDE-5 Inhibition in End-Stage Multiple Myeloma

Cancer immunology research, 2014-03, Vol.2 (8), p.725-731

2014

Volltextzugriff (PDF)

Th-17 Lymphocytes, Not Regulatory T Cells, Mediate Immune Regulation of Bone Marrow Infiltrating Lymphocytes and Induce Osteoclast Activation in Multiple Myeloma

Blood, 2007-11, Vol.110 (11), p.811-811

2007

Volltextzugriff (PDF)

CD4+CD25+ Marrow Infiltrating Lymphocytes in Myeloma Patients Display an Activated Phenotype and Lack Suppressive Function

Blood, 2006-11, Vol.108 (11), p.1741-1741

2006

Volltextzugriff (PDF)

Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links

Genes & development, 2020-06, Vol.34 (11-12), p.832-846

2020

Volltextzugriff (PDF)

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2017-10, Vol.35 (28), p.3240-3261

2017

Volltextzugriff (PDF)

Antiemetics: ASCO Guideline Update

Journal of clinical oncology, 2020-08, Vol.38 (24), p.2782-2797

2020

Volltextzugriff (PDF)

Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5439-5449

2008

Volltextzugriff (PDF)

A Lanthanide Phosphinidene Complex: Synthesis, Structure, and Phospha-Wittig Reactivity

Journal of the American Chemical Society, 2008-02, Vol.130 (8), p.2408-2409

2008

Volltextzugriff (PDF)

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

The Journal of experimental medicine, 2006-11, Vol.203 (12), p.2691-2702

2006

Volltextzugriff (PDF)

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

Blood, 2010-11, Vol.116 (18), p.3554-3563

2010

Volltextzugriff (PDF)

Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma

Seminars in oncology nursing, 2017-08, Vol.33 (3), p.279-291

2017

Volltextzugriff (PDF)

Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor

Clinical lymphoma, myeloma and leukemia, 2020-06, Vol.20 (6), p.351-357

2020

Volltextzugriff (PDF)

The Immune Microenvironment of Myeloma

Cancer microenvironment, 2011-12, Vol.4 (3), p.313-323

2011

Volltextzugriff (PDF)

Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity

Journal of immunotherapy (1997), 2019-04, Vol.42 (3), p.73

2019

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(103)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(49)
Humans
(42)
Oncology
(22)
Female
(20)
Male
(18)
Middle Aged
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Hematology
(11)
Multiple Myeloma
(11)
Adult
(10)
Bone Marrow
(10)
Multiple Myeloma - Drug Therapy
(9)
Aged
(8)
Nursing
(8)
Tumors
(8)
Animals
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Mice
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma

Flow cytometric discrimination of seven lineage markers by using two fluorochromes

Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma

Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma

An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission

Marrow-Infiltrating Lymphocytes - Role in Biology and Cancer Therapy

Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma

Persistence of Non Gene-Modified Adoptively Transferred Marrow Infiltrating Lymphocytes (MILs) More Than Five Years Post Transfer

Targeting Immune Suppression with PDE-5 Inhibition in End-Stage Multiple Myeloma

Th-17 Lymphocytes, Not Regulatory T Cells, Mediate Immune Regulation of Bone Marrow Infiltrating Lymphocytes and Induce Osteoclast Activation in Multiple Myeloma

CD4+CD25+ Marrow Infiltrating Lymphocytes in Myeloma Patients Display an Activated Phenotype and Lack Suppressive Function

Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Antiemetics: ASCO Guideline Update

Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

A Lanthanide Phosphinidene Complex: Synthesis, Structure, and Phospha-Wittig Reactivity

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma

Consensus Recommendations for the Clinical Management of Patients With Multiple Myeloma Treated With Selinexor

The Immune Microenvironment of Myeloma

Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity

Suchergebnisse filtern